Cipla, Ltd - Virgonagar Site Old Madras Road, Virgonagar
Form 483 issued July 15, 2019 · Bangalore, India
- Observations
- 1
- Pages
- 6
- FEI number
- 3002806691
In short: On July 15, 2019, FDA issued a Form 483 with 1 observation to Cipla, Ltd - Virgonagar Site Old Madras Road, Virgonagar in Bangalore, India (FEI 3002806691). Most observations concern quality system; the most-cited regulation is 21 CFR 211.192 (production record review).
At a glance
1 of 1 observations on this 483 concern quality system.
Most cited: 21 CFR 211.192 (1×)
What FDA observed
Preview: the opening words of each observationDashed: section inferred by FDA Intel and checked against the regulation text
- 01
Investigations into out-of-specification (OOS) QC analytical results, related to finished API product quality…
This inspection in context
Questions about this 483
What did FDA find at Cipla, Ltd - Virgonagar Site Old Madras Road, Virgonagar?
FDA listed 1 observation on this Form 483, mostly about quality system. The most-cited regulation is 21 CFR 211.192 (production record review). The opening words of each observation are shown on this page.
When was Cipla, Ltd - Virgonagar Site Old Madras Road, Virgonagar inspected by FDA?
This Form 483 is dated July 15, 2019.
How do I get the full Form 483 for Cipla, Ltd - Virgonagar Site Old Madras Road, Virgonagar?
Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.